SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tejeda HA, Green SB, Trimble EL, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 1996; 88: 812816.
  • 2
    Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer. 1994; 74 (Suppl): 22082214.
  • 3
    Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years or age or older in cancer treatment trials. N Engl J Med. 1999; 341: 20612067.
  • 4
    Kemeny MM, Muss HE, Kornblith AB, Peterson B, Wheeler J, Cohen HJ. Barriers to participation of older women with breast cancer in clinical trials (abstract 2371). Proc Am Soc Clin Oncol. 2000; 19: 602a.
  • 5
    Butler RN. Ageism. In: MaddoxGL, editor. The encyclopedia of aging. New York: Springer Publishing, 1987: 2223.
  • 6
    Taylor KM, Feldstein ML, Skeel RT, Pandya KJ, Ng P, Carbone PP. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1737 Eastern Cooperative Oncology Group investigators. J Clin Oncol. 1994; 12: 17961805.
  • 7
    Ellis PM. Attitudes toward and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol. 2000; 11: 939945.
  • 8
    Lara PN, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001; 19: 17281733.
  • 9
    Siminoff LA, Zhang A, Colabianchi N, Sturm CMS, Shen Q. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol. 2000; 18: 12031211.
  • 10
    Gotay CC. Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med. 1991; 33: 569577.
  • 11
    Benson AB, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol. 1991; 9: 20672075.
  • 12
    Giovanazzi-Bannon S, Rademaker A, Lai G, Benson AB. Treatment tolerance of elderly cancer patients entered onto Phase II clinical trials: an Illinois Cancer Center study. J Clin Oncol. 1994; 12: 24472452.
  • 13
    Crivellari D, Bonetti M, Castiglione-Gertsch M, et al. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII. J Clin Oncol. 2000; 18: 14121422.
  • 14
    Kearney N, Miller N. Elderly patients with cancer: an ethical dilemma. Crit Rev Oncol Hematol. 2000; 33: 149154.
  • 15
    Hoffman SB. Communication strategies with older cancer patients and their families. In: BalducciL, LymanGH, ErshlerWB, editors. Geriatric oncology. Philadelphia: JB Lippincott, 1992: 356364.